Lunchtime Live

HSE approves offer on Skyclarys drug for Friedreich's Ataxia patients

13 min · I går
Billede af episoden HSE approves offer on Skyclarys drug for Friedreich's Ataxia patients

Beskrivelse

The HSE today has approved a new offer from drug firm Biogen over ‘Skyclarys’, which will now be available with reimbursement to Friedreich’s Ataxia patients. This comes after mounting pressure, and months of campaigning… Joining Clare McKenna to discuss this is Teresa Kane, a mother of two children with Friedreich’s Ataxia and Niamh Ní Hoireabhaird, who lives with Friedrich’s Ataxia…

Kommentarer

0

Vær den første til at kommentere

Tilmeld dig nu og bliv en del af Lunchtime Live-fællesskabet!

Prøv gratis

Prøv gratis i 14 dage

99 kr. / måned efter prøveperioden. · Opsig når som helst

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

Alle episoder

298 episoder